Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial

JAMA Netw Open. 2022 Sep 1;5(9):e2230451. doi: 10.1001/jamanetworkopen.2022.30451.

Authors

Omar Abdel-Mannan^{1

2}, Olga Ciccarelli^{1

3}, Yael Hacohen^{1

2}

Affiliations

¹ Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom.
² Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom.
³ NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.

PMID: 36169961
DOI: 10.1001/jamanetworkopen.2022.30451

No abstract available

Publication types

Comment

MeSH terms

Child
Humans
Multiple Sclerosis* / drug therapy
Pediatrics
Randomized Controlled Trials as Topic